SPRO
SPRO
NASDAQ · Biotechnology

Spero Therapeutics Inc

$1.03
+0.01 (+0.98%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,942.7% upside
Low Target $21.51
Average Target $31.34
High Target $48.77
Current Price $1.03
Current
$1.03
Target
$31.34
$21.51 $31.34 avg $48.77
Scenario Analysis
Bear Case
$21.51
1,988.3%
Low target
Base Case
$31.34
+2,942.7%
Avg target
Bull Case
$48.77
+4,635.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.08
-66.6% from high
52-Week Low
$0.96
+7.2% from low
Target vs 52W High
$31.34
+917.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%